stella
beta
Find trials matched to me
Trial Match
131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD) — Stella
Recruiting
Back to Sickling Disorder Due to Hemoglobin S trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Trial locations
(1 site)
United States
Columbia University Irving Medical Center, New York, New York
View full record on ClinicalTrials.gov